| Literature DB >> 24894914 |
Abstract
Mutant mice have been used successfully as a tool for investigating the mechanisms of memory at multiple levels, from genes to behavior. In most cases, manipulating a gene expressed in the brain impairs cognitive functions such as memory and their underlying cellular mechanisms, including synaptic plasticity. However, a remarkable number of mutations have been shown to enhance memory in mice. Understanding how to improve a system provides valuable insights into how the system works under normal conditions, because this involves understanding what the crucial components are. Therefore, more can be learned about the basic mechanisms of memory by studying mutant mice with enhanced memory. This review will summarize the genes and signaling pathways that are altered in the mutants with enhanced memory, as well as their roles in synaptic plasticity. Finally, I will discuss how knowledge of memory-enhancing mechanisms could be used to develop treatments for cognitive disorders associated with impaired plasticity.Entities:
Mesh:
Substances:
Year: 2014 PMID: 24894914 PMCID: PMC4050447 DOI: 10.1186/1756-6606-7-43
Source DB: PubMed Journal: Mol Brain ISSN: 1756-6606 Impact factor: 4.041
Figure 1Molecules involved in memory enhancement. Signaling pathways in the presynaptic axonal terminal and the postsynaptic dendritic spine and nucleus are illustrated in a simplified manner. Green and red arrows indicate positive and negative regulations, respectively. Memory is enhanced either by the over expression/activation of molecules colored in green or the deletion/inhibition of molecules in red. The detailed roles of some of these molecules in LTP and memory are described in the text. Cbl-b, casitas B-lineage lymphoma-b; NCX2, Na+/Ca2+ exchanger type 2; GAP-43, growth-associated protein 43; tPA, tissue-type plasminogen activator; HB-GAM, heparin-binding growth-associated molecule; MMP-9, Matrix metallopeptidase 9; GABA, γ-aminobutyric acid; MAGL, Monoacylglycerol lipase; CaMKII, calcium calmodulin kinase II; BDNF, Brain-derived neurotrophic factor; Cdk5, Cyclin-dependent kinase 5; Cavβ3, beta intracellular subunit of the voltage-gated calcium channel; PKA, protein kinase A; PDE, phosphodiesterase; PP1, protein phosphatase 1; MAPK, mitogen-activated protein kinase; CaMKIV, calcium calmodulin kinase IV; CN, calcineurin; ATF4, activating transcription factor 4; GCN2, general control nonderepressible 2; p-eIF2α, phosphorylated eukaryotic translation initiation factor 2 subunit α.
Mutant mice with enhanced memory
| Enhanced in MWM, CFC, ORT, NMT | Enhanced CA1 LTP | [ | |
| Enhanced in CFC, reversal learning in MWM | Enhanced CA1 LTP | [ | |
| Enhanced in MWM, CFC | Enhanced CA1 LTP | [ | |
| Enhanced in MWM, DMT | Not determined | [ | |
| Enhanced in MWM, CFC, PA | Enhanced CA1 LTP | [ | |
| Enhanced in MWM | Not determined | [ | |
| Enhanced in MWM | Enhanced CA1 LTP | [ | |
| Enhanced in MWM | Enhanced CA1 LTP | [ | |
| | | | |
| Enhanced in MWM, CFC | Enhanced CA1, cortical LTP | [ | |
| Enhanced in MWM, CFC, ORT | Enhanced CA1 LTP | [ | |
| Enhanced in MWM (remote memory) | No change in CA1 LTP | [ | |
| Enhanced in MWM | Enhanced CA1 LTP | [ | |
| Enhanced in CFC, TFC | Not determined | [ | |
| Enhanced in MWM, ORT | Enhanced CA1 LTP | [ | |
| Enhanced in MWM, CFC, AFC | Enhanced CA1 LTP | [ | |
| Enhanced in MWM | Trend of enhanced CA1 LTP | [ | |
| Enhanced in CFC, AFC | Enhanced amygdala LTP | [ | |
| | | | |
| Enhanced in MWM, YM | No change in CA1 LTP; Impaired LTP in Tg | [ | |
| Enhanced in MWM (aged mice only) | Enhanced CA1 LTP (aged mice only) | [ | |
| Enhanced in MWM | Enhanced perforant path LTP | [ | |
| CREB-Y134F Tg | Enhanced in MWM, CFC, SR, CD | Enhanced CA1 LTP | [ |
| CREB-DIEDML Tg | Enhanced in CFC, SR | Not determined | [ |
| eIF2αS51A KI | Enhanced in MWM, CFC, AFC | Enhanced CA1 LTP | [ |
| Enhanced in MWM, impaired in CFC | Enhanced CA1 LTP | [ | |
| ATF4, C/EBP CI | Enhanced in MWM | Enhanced CA1 LTP | [ |
| Enhanced in CFC | Enhanced CA1 LTP | [ | |
| Enhanced in ORT | Enhanced CA1 LTP | [ | |
| Enhanced in CFC, ORT | Enhanced CA1 LTP | [ | |
| Enhanced in MWM, RAM, ORT | Not determined, but see
[ | [ | |
| Enhanced in MWM, CFC | Not determined | [ | |
| Calcineurin CI | Enhanced in MWM, AFC, ORT | Enhanced CA1 LTP | [ |
| PP1 CI | Enhanced in MWM, ORT | Enhanced CA1 LTP | [ |
| | | | |
| Enhanced in MWM, OLT, CFC | Enhanced CA1 L-LTP | [ | |
| Enhanced in CFC | Enhanced CA1 L-LTP | [ | |
| | | | |
| Enhanced in CFC, AFC, NMT | Enhanced CA1 LTP | [ | |
| | | | |
| Enhanced in MWM, CFC, TFC | Enhanced CA1 LTP | [ | |
| | | | |
| Enhanced in MWM, ORT | Enhanced CA1 LTP | [ | |
| Enhanced in MWM | Enhanced CA1 LTP | [ | |
| Enhanced in MWM | Enhanced CA1 LTP | [ | |
| | | | |
| Enhanced in MWM, ORT | Enhanced perforant path LTP | [ | |
| Enhanced in MWM (learning), ORT | Enhanced CA2 LTP | [ | |
| Enhanced in CFC | Not determined | [ | |
| Enhanced in CFC, AFC | Not determined | [ | |
| Enhanced in MWM, CFC, AFC | Enhanced CA1 LTP | [ | |
| Enhanced in MWM, ORT | Not determined | [ | |
| Enhanced in MWM, impaired CFC | Enhanced CA1 LTP | [ | |
| Enhanced in MWM, CFC | Enhanced CA1 LTP | [ | |
Tg, transgenic; KO, knockout; KI, knock-in; cKO, conditional KO; CI, conditional inhibition; MWM, Morris water maze; CFC, contextual fear conditioning; AFC, auditory fear conditioning; TFC, trace fear conditioning; ORT, object recognition test; OLT, object location test; RAM, radial arm maze; SR, social recognition; DMT, delay matching to place task; NMT, non-match to place task; YM, Y-maze; L-LTP, late phase LTP.
LTP enhancement without memory enhancement
| Enhanced CA1 LTP | Impaired in MWM | [ | |
| Enhanced CA1 LTP | Normal initial learning, impaired reversal learning in MWM | [ | |
| Enhanced CA1 LTP | Impaired in MWM | [ | |
| Enhanced CA1 and CA3 LTP | Impaired in MWM, RAM | [ | |
| Enhanced CA1 LTP | Impaired in MWM, ORT | [ | |
| Enhanced CA1 LTP | Impaired in CFC, PA, ORT; but normal in MWM | [ | |
| Enhanced CA1 LTP | Impaired in CFC, MWM | [ | |
| Enhanced CA1 LTP | Impaired in MWM, ORT | [ | |
| Enhanced CA1 LTP | Impaired in MWM, CFC* | [ | |
| Enhanced CA1 LTP | Impaired in MWM | [ | |
| Enhanced CA1 LTP | Impaired in CFC, but normal in MWM | [ | |
| Enhanced cortical LTP | Impaired in MWM (21 days), CFC (1 day) | [ | |
| Enhanced CA1 LTP | No change in MWM | [ |
KO, knockout; Tg, transgenic; KI, knock-in; MWM, Morris water maze; RAM, radial arm maze; ORT, object recognition test; CFC, contextual fear conditioning; PA, passive avoidance; *impaired in contextual discrimination test.